The Association Between HLA Class II Alleles and the Occurrence of Factor VIII Inhibitor in Thai Patients with Hemophilia A

被引:7
作者
Nathalang, Oytip [1 ]
Sriwanitchrak, Pramote [1 ]
Sasanakul, Werasak [2 ]
Chuansumrit, Ampaiwan [2 ]
机构
[1] Thammasat Univ, Fac Allied Hlth Sci, Dept Med Technol, Pathum Thani, Thailand
[2] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pediat, Bangkok 10400, Thailand
关键词
HLA class II alleles; FVIII inhibitor; Hemophilia A; Thais; RECOMBINANT FACTOR-VIII; GENOTYPE; MUTATION; RISK; INVERSION; RESPONSES; GENE;
D O I
10.5505/tjh.2012.29795
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study aimed to investigate the association between HLA class II alleles and the occurrence of FVIII inhibitor in Thai hemophilia A patients. Material and Methods: The distribution of HLA-DRB1 alleles and DQB1 alleles in 57 Thai hemophilia A patients and 36 blood donors as controls was determined using the PCR sequence-specific primer (PCR-SSP) method, and the association between the occurrence of factor VIII (FVIII) inhibitor and the presence of certain HLA class II alleles was investigated. Results: The frequency of HLA-DRB1*15 was higher in the hemophilia A patients with and without FVIII inhibitor, whereas that of DRB1*14, DRB1*07, and DQB1*02 was lower in the hemophilia A patients with FVIII inhibitor, as compared to controls. Interestingly, only the frequency of DRB1*15 was significantly higher in the patients with inhibitor than in the controls (P = 0.021). Moreover, the frequency of DRB1*15 in the patients with inhibitor was higher than in those without inhibitor (P = 0.198). Conclusion: The study's findings show that the DRB1*15 allele might have contributed to the occurrence of inhibitor in the Thai hemophilia A patients; however, additional research using larger samples and high-resolution DRB1 typing is warranted.
引用
收藏
页码:34 / 39
页数:6
相关论文
共 27 条
[1]   FREQUENCY OF INHIBITOR DEVELOPMENT IN HEMOPHILIACS TREATED WITH LOW-PURITY FACTOR-VIII [J].
ADDIEGO, J ;
KASPER, C ;
ABILDGAARD, C ;
HILGARTNER, M ;
LUSHER, J ;
GLADER, B ;
ALEDORT, L .
LANCET, 1993, 342 (8869) :462-464
[2]   FACTOR-VIII GENE INVERSIONS IN SEVERE HEMOPHILIA-A - RESULTS OF AN INTERNATIONAL CONSORTIUM STUDY [J].
ANTONARAKIS, SE ;
ROSSITER, JP ;
YOUNG, M ;
HORST, J ;
DEMOERLOOSE, P ;
SOMMER, SS ;
KETTERLING, RP ;
KAZAZIAN, HH ;
NEGRIER, C ;
VINCIGUERRA, C ;
GITSCHIER, J ;
GOOSSENS, M ;
GIRODON, E ;
GHANEM, N ;
PLASSA, F ;
LAVERGNE, JM ;
VIDAUD, M ;
COSTA, JM ;
LAURIAN, Y ;
LIN, SW ;
LIN, SR ;
SHEN, MC ;
LILLICRAP, D ;
TAYLOR, SAM ;
WINDSOR, S ;
VALLEIX, SV ;
NAFA, K ;
SULTAN, Y ;
DELPECH, M ;
VNENCAKJONES, CL ;
PHILLIPS, JA ;
LJUNG, RCR ;
KOUMBARELIS, E ;
GIALERAKI, A ;
MANDALAKI, T ;
JENKINS, PV ;
COLLINS, PW ;
PASI, KJ ;
GOODEVE, A ;
PEAKE, I ;
PRESTON, FE ;
SCHWARTZ, M ;
SCHEIBEL, E ;
INGERSLEV, J ;
COOPER, DN ;
MILLAR, DS ;
KAKKAR, VV ;
GIANNELLI, F ;
NAYLOR, JA ;
TIZZANO, EF .
BLOOD, 1995, 86 (06) :2206-2212
[3]   Basic aspects of inhibitors to factors VIII and IX and the influence of non-genetic risk factors [J].
Astermark, J. .
HAEMOPHILIA, 2006, 12 :8-13
[4]   The Malmo International Brother Study (MIBS): further support for genetic predisposition to inhibitor development [J].
Astermark, J ;
Berntorp, E ;
White, GC ;
Kroner, BL .
HAEMOPHILIA, 2001, 7 (03) :267-272
[5]  
BRAY GL, 1994, BLOOD, V83, P2428
[6]   HLA class II genotype and factor VIII inhibitors in mild haemophilia A patients with an Arg593 to Cys mutation [J].
Bril, WS ;
MacLean, PE ;
Kaijen, PHP ;
Van den Brink, EN ;
Lardy, NM ;
Fijnvandraat, K ;
Peters, M ;
Voorberg, J .
HAEMOPHILIA, 2004, 10 (05) :509-514
[7]   SPECIFICITY AND PROMISCUITY AMONG NATURALLY PROCESSED PEPTIDES BOUND TO HLA-DR ALLELES [J].
CHICZ, RM ;
URBAN, RG ;
GORGA, JC ;
VIGNALI, DAA ;
LANE, WS ;
STROMINGER, JL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (01) :27-47
[8]  
DEBIASI R, 1994, THROMB HAEMOSTASIS, V71, P544
[9]  
Hay CRM, 1997, THROMB HAEMOSTASIS, V77, P234
[10]   CD4+ T-cell clones specific for wild-type factor VIII:: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia A [J].
Jacquemin, M ;
Vantomme, V ;
Buhot, C ;
Lavend'homme, R ;
Burny, W ;
Demotte, N ;
Chaux, P ;
Peerlinck, K ;
Vermylen, J ;
Maillere, B ;
van der Bruggen, P ;
Saint-Remy, JM .
BLOOD, 2003, 101 (04) :1351-1358